The mean adherence rate in the study population was 96.3% (standard deviation, SD: 7.7).
研究人群中的平均依从率为96.3％（标准差,SD：7.7）。
Marriage rank could be related to testosterone levels in our study population, but we lack the data to investigate this.
在我们的研究人群中，婚姻地位与睾酮水平有关，但我们缺乏数据去进一步研究。
Methods:The study population consisted of 57 advanced ESCC patients.
方法：本研究包含了57例晚期ESCC患者。
Seroquel use was associated with a nearly threefold adjusted increase in risk among the study population.
使用思瑞康与研究人群中校正风险增加接近3倍有关。
The study population consisted of 13 patients with left-sided MTLE, 10 with right-sided MTLE, and 21 controls.
实验一共纳入13例左侧起源的颞叶内侧癫痫病人，10例右侧起源的颞叶内侧癫痫病人和21例对照。
The total incidence of these 3 cancers in the study population is 63% higher in current users of HRT than in never users.
该研究受试人群中，正在使用HRT者这3种癌症的总发病率比从不使用HRT者高63％。
Study limitations include the fact that lung function was measured only once and a relatively homogenous study population.
研究的局限性包括肺功能只测试一次以及研究人群相对均一的事实。
Methods. The study population consisted of 3 patient groups evaluated by MRI 2 to 5 days after lumbar decompression with or without fusion.
方法：研究人群包括腰椎减压伴或不伴融合术后2到5天接受MRI评估的3个病例组。
Because there is no folic acid fortification of foods in Norway, the study population offered a good way to test for the effects of folic acid on cancer risk.
因为挪威未在食物中加入叶酸，要证实叶酸是否对癌症发病风险存在影响，上述的研究是一个很好的方案。
The study population comprised 6,319 consecutive patients who underwent implantation of an antiarrhythmic system at one of 44 participating medical centers in France.
研究对象来自于法国的44个医学中心，共计6,319例序贯患者接受了抗心律失常电子装置的植入术。
Randomized controlled trials with a study population with at least 50% of the subjects having no history of coronary heart disease and 12 or more months of follow-up were included.
受试者中至少50%无冠心病病史，随访大于等于12个月的随机对照试验入选本次分析。
Here again, superiority was observed for the entire study population and in the poorest prognosis groups, including liver and other visceral involvement, and prior adjuvant chemotherapy.
再一次地，这种优势体现在整个研究人群和预后最差的亚组，包括肝脏和其它内脏受累及曾接受辅助化疗的患者。
No adverse events from olmesartan were observed on renal outcomes, and the incidence of cardiovascular morbidity and mortality was low overall, affecting fewer than 1% of the entire study population.
奥美沙坦组没有出现任何累及肾脏转归的不良事件。总的来看，心血管疾病的发病率和病死率很低，不足整个受试人群的1%。
No adverse events from olmesartan were observed on renal outcomes, and the incidence of cardiovascular morbidity and mortality was low overall, affecting fewer than 1% of the entire study population.
奥美沙坦组没有出现任何累及肾脏转归的不良事件。总的来看，心血管疾病的发病率和病死率很低，不足整个受试人群的1%。
应用推荐